Goyang-si, South Korea

Joong Won Lee

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • Goyang-si, KR (2019 - 2021)
  • Gwangmyeong-si, KR (2020 - 2021)
  • Seoul, KR (2024)

Company Filing History:


Years Active: 2019-2024

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: The Innovations of Joong Won Lee

Introduction

Joong Won Lee is a prominent inventor based in Goyang-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of six patents to his name, his work has the potential to impact cancer treatment and immunotherapy.

Latest Patents

One of Joong Won Lee's latest patents focuses on anti-human 4-1BB antibodies and their uses. This patent provides anti-human 4-1BB antibodies and fragments that possess unique structural features not found in reference antibodies. These features may enhance certain characteristics of the antibody, improving its efficacy. The patent also outlines various in vitro and in vivo methods and reagents related to these antibodies. Methods include inducing T-cell proliferation, promoting T-cell secretion of IFNγ, and utilizing the antibodies for the detection, prevention, and therapeutic treatment of cancer.

Career Highlights

Joong Won Lee has established himself as a key figure in his field through his innovative research and development efforts. His work at Eutilex Co., Ltd. has allowed him to collaborate with other experts and contribute to advancements in antibody technology. His dedication to improving cancer therapies through his inventions is commendable.

Collaborations

Some of Joong Won Lee's notable coworkers include Byoung S Kwon and Seoung-Joo Lee. Their collaborative efforts have likely played a role in the success of their projects and patents.

Conclusion

Joong Won Lee's contributions to the field of biotechnology, particularly through his patents on anti-human 4-1BB antibodies, highlight his innovative spirit and commitment to advancing cancer treatment. His work continues to pave the way for new therapeutic approaches in immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…